膀胱内灌注卡介苗致多器官功能衰竭1例分析

doi:10.19803/j.1672-8629.20240055

中国药物警戒 ›› 2024, Vol. 21 ›› Issue (6): 697-699.
DOI: 10.19803/j.1672-8629.20240055

膀胱内灌注卡介苗致多器官功能衰竭1例分析

徐钰行¹, 弓清梅^1,*, 骆宇琛¹, 王宗隅¹, 张囝²

¹山西省人民医院,山西医科大学第五临床医学院重症医学科,山西太原 030012;
²河津市人民医院急诊科,山西河津 043300

收稿日期:2024-01-25 出版日期:2024-06-15 发布日期:2024-06-18
通讯作者: ^*弓清梅,女,硕士,主任医师,重症医学。E-mail: ty_gqm@163.com
作者简介:徐钰行,女,在读研究生,全科医学。
基金资助:
山西省人民医院“136兴医工程”省级专项配套经费科研项目（2019018）

One case of multiple organ failure caused by intravesical infusion of BCG vaccine

XU Yuhang¹, GONG Qingmei^1,*, LUO Yuchen¹, WANG Zongyu¹, ZHANG Jian²

¹Department of Intensive Care Unit, Shanxi Provincial People’s Hospital/The Fifth Clinical Medical College of Shanxi Medical University, Taiyuan Shanxi 030012, China;
²Emergency Department of Hejin People’s Hospital, Hejin Shanxi 043300, China

Received:2024-01-25 Online:2024-06-15 Published:2024-06-18

摘要/Abstract

摘要： 目的关注膀胱灌注卡介苗后引起的并发症,探讨发病机制,为临床应用提供参考。方法分析膀胱内灌注卡介苗致多器官功能衰竭的病例,查阅文献对此并发症发病率、发病机制、临床表现等进行讨论。结果该患者经升压、经验性抗感染、抗休克、抗结核、补液等对症治疗后,实验室指标回升,病情好转出院。但患者仍不能排除播散性结核感染的可能,过敏反应也有可能参与其中。结论虽然大部分患者对膀胱灌注卡介苗耐受性良好,但仍需警惕其发生脓毒血症的可能。

关键词: 卡介苗, 膀胱灌注治疗, 膀胱肿瘤, 多器官功能衰竭, 脓毒血症, 不良反应

Abstract: Objective To explore the pathogenesis of complications arising from bladder instillation of the BCG vaccine in order to provide data for clinical applications. Methods One case of multiple organ failure caused by intravesical instillation of the BCG vaccine was analyzed. Related literature was reviewed while the incidence, pathogenesis and clinical manifestations of this complication were analyzed. Results The patient was discharged from the hospital in better condition after symptomatic treatment, involving blood pressure elevation, anti-infection, anti-shock and anti-tuberculosis medications as well as rehydration. The related laboratory indicators of the patient improved. However, the possibility of disseminated tuberculosis could not be ruled out, and allergic reactions might also be involved, which needed to be studied. Conclusion Although the majority of patients are well tolerant of bladder instillation of the BCG vaccine, clinicians need to be alert to its the risk of sepsis.

Key words: Bacillus Calmette-Guérin, intravesical therapy, bladder cancer, multi-organ failure, sepsis, adverse reaction

中图分类号:

R915

徐钰行, 弓清梅, 骆宇琛, 王宗隅, 张囝. 膀胱内灌注卡介苗致多器官功能衰竭1例分析[J]. 中国药物警戒, 2024, 21(6): 697-699.

XU Yuhang, GONG Qingmei, LUO Yuchen, WANG Zongyu, ZHANG Jian. One case of multiple organ failure caused by intravesical infusion of BCG vaccine[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 697-699.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://zgywjj.magtechjournal.com/CN/10.19803/j.1672-8629.20240055

https://zgywjj.magtechjournal.com/CN/Y2024/V21/I6/697

参考文献

[1] MORALES A, EIDINGER D, BRUCE AW.Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors[J]. The Journal of Urology, 1976, 116(2): 180-183.
[2] SUNG H, FERLAY J, SIEGEL RL, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: A Cancer Journal for Clinicians, 2021, 71(3): 209-249.
[3] LI HZ, ZHENG RS, DU LB, et al.Bladder cancer incidence, mortality and temporal trends in China[J]. Chinese Journal of Oncology(中华肿瘤杂志), 2021, 43(3): 293-298.
[4] FERNANDES PF, NUNES P, FIGUEIREDO A, et al.Septic shock after intravesical therapy with bacillus calmette-guerin: a case report of a rare life-threatening complication[J]. Cureus, 2023, 15(10): e46563.
[5] MARQUES M, VAZQUEZ D, SOUSA S, et al.Disseminated Bacillus Calmette-Guérin (BCG) infection with pulmonary and renal involvement: a rare complication of BCG immunotherapy. A case report and narrative review[J]. Pulmonology, 2020, 26(6): 346-352.
[6] Urological Chinese Oncology Group. Expert consensus on intravesical therapy for non-muscle invasive bladder cancer (2021 edition)[J]. Chinese Journal of Oncology(中华肿瘤杂志), 2021, 43(10): 1027-1033.
[7] HAN J, GU X, LI Y, et al.Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect[J]. Biomedicine & Pharmacotherapy, 2020, 129: 110393.
[8] EZHILARASAN D.Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms[J]. Drug Metabolism Reviews, 2023, 55(3): 239-253.
[9] YONG C, STEINBERG RL, O'DONNELL MA. Severe infectious complications of intravesical Bacillus Calmette-Guérin: a case series of 10 patients[J]. Urology, 2020, 137: 79-83.
[10] YAN DL, ZHI HM, WANG XH, et al.A case of multiple organ failure due to bladder instillation of BCG vaccine[J]. Journal of Clinical Urology(临床泌尿外科杂志), 2004, 19(8): 488.
[11] YANG Y, QIN WC, LI YY, et al.Two complications of BCG bladder instillation[J]. Medical Journal of Chinese People's Liberation Army(解放军医学杂志), 2001, 26(12): 933.
[12] ESCOBAR GIL T, BORJA MONTES OF, SHEIKH AB.Unraveling Bacillus Calmette-Guérin (BCG) therapy side effects in bladder cancer: a tale of triumph over treatment challenges[J]. Cureus, 2023, 15(12): e50498.
[13] MAROULI D, PAPPAS C, RAISSAKI M, et al.Disseminated Bacillus Calmette-Guérin (BCG) infection presenting as severe respiratory failure and septic shock[J]. Germs, 2023, 13(3): 277-281.
[14] ANDRADE E SILVA UV, VIANA LS, OLIVEIRA E CASTRO PT, et al. Fatal sepsis after intravesical instillation of BCG: case report[J]. Revista Brasileira de Terapia Intensiva, 2011, 23(1): 104-107.
[15] GÁLVEZ-L PEZ R, RUIZ-CARAZO E, LÁINEZ -RAMOS-BOSSINI AJ, et al. Miliary tuberculosis secondary to intravesical instillation of Bacillus Calmette-Guérin. Report of two cases[J]. Infectious Diseases Now, 2021, 51(2): 213-215.
[16] OLIVEIRA AA, MORAIS J, RIBEIRO J, et al.Systemic infection following intravesical therapy with BCG[J]. BMJ Case Reports CP, 2021, 14(11): e243641.

膀胱内灌注卡介苗致多器官功能衰竭1例分析

One case of multiple organ failure caused by intravesical infusion of BCG vaccine

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	路振凯, 杨顶权, 谢振年, 王连心, 黎元元, 王志飞, 崔鑫, 谢雁鸣. 《外用中成药临床应用药物警戒指南》解读与启示[J]. 中国药物警戒, 2024, 21(9): 1029-1033.
[2]	孟康康, 夏玉坤. 昂丹司琼制剂安全性风险分析[J]. 中国药物警戒, 2024, 21(9): 1034-1038.
[3]	林璐, 詹陆川, 刘晓琦, 刘菊娥, 王来友, 曾颖, 赖伟华. 基于中国医院药物警戒系统建立地高辛不良事件主动监测电子触发器[J]. 中国药物警戒, 2024, 21(9): 1039-1043.
[4]	王以金, 唐静, 杨超, 徐凯, 张梦蝶, 高健, 吴晓丽, 张粤, 牛晓兵, 蒋鹤松, 茆飞, 周闪, 姜熙, 郭忠英, 孙苏安, 徐明, 徐宗源, 王恒兵, 李歆, 傅广波. 小剂量注射吉西他滨联合经尿道膀胱肿瘤电切术治疗中高危非肌层浸润性膀胱癌的临床研究[J]. 中国药物警戒, 2024, 21(9): 1044-1050.
[5]	吴凡, 付林杰, 祝赫, 徐梦艳. 基于美国FAERS和日本JADER数据库的内皮素受体拮抗剂不良事件信号分析[J]. 中国药物警戒, 2024, 21(9): 1056-1063.
[6]	张彩霞, 周易, 谭璐, 陈文明, 柳阳, 游禹. 1例脓毒血症继发肺曲霉菌感染患者的药学监护[J]. 中国药物警戒, 2024, 21(9): 1064-1067.
[7]	严妍, 刘乃一, 乔玲, 张毅, 杨晨. 别嘌醇片诱导的超敏反应综合征致暴发性1型糖尿病1例分析[J]. 中国药物警戒, 2024, 21(9): 1068-1070.
[8]	卢靖, 喻珊珊, 童菲, 林卓慧, 宋路瑶. 达格列净片致严重便秘1例分析[J]. 中国药物警戒, 2024, 21(9): 1071-1074.
[9]	刘婷, 曹忠强, 何文佳, 袁秀丽, 陈泽彬, 李学娟. 培门冬酶注射液致急性重症胰腺炎1例分析[J]. 中国药物警戒, 2024, 21(9): 1075-1077.
[10]	魏芬芳, 吴文宇, 李丽敏, 唐碧雨, 吴建茹. 国外药品获益-风险评价方法概述与启示[J]. 中国药物警戒, 2024, 21(8): 900-905.
[11]	王玉玺, 张宗林, 王颖丽, 陈亚飞, 李俊生, 霍艳飞, 谢彦军, 刘文启. 560例脉络舒通丸不良反应/事件报告分析[J]. 中国药物警戒, 2024, 21(8): 921-924.
[12]	赵俊, 董丽, 王洋, 梁瑜, 杨雪, 李恩泽. 艾司洛尔不良反应/事件报告分析[J]. 中国药物警戒, 2024, 21(8): 925-930.
[13]	张乾, 恽渊, 何恋. 1例利培酮致高泌乳素血症患者的药学监护[J]. 中国药物警戒, 2024, 21(8): 936-938.
[14]	李芳, 龙秀英, 柏娜, 魏京霞. 阿托伐他汀钙片致全身严重皮疹1例分析[J]. 中国药物警戒, 2024, 21(8): 939-942.
[15]	晁滢, 张学梅, 张成健, 王贝. 注射用头孢曲松钠致儿童输尿管结石及胆囊结石1例分析[J]. 中国药物警戒, 2024, 21(8): 943-945.